| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.62 | 6e-05 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |